Alpha-mangostin combined with doxorubicin-loaded hydrogel for the treatment of ovarian cancer
Journal of Materials Chemistry B · 2026 · 14 (43) · 13470-13481
DOI: 10.1039/d6tb02158a ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2026. Verfasst von Xia Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, 610041, P. R. China. …. Hauptthemen laut MEDLINE: Xanthones, Doxorubicin, Ovarian Neoplasms, Hydrogels. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
A thermosensitive hydrogel co-delivering an α-mangostin nanoformulation and doxorubicin achieved synergistic efficacy in ovarian cancer treatment, demonstrating superior antitumor effects versus monotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, 610041, P. R. China. liujie2011@scu.edu.cn.
- Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, 610041, P. R. China.
- Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong, China.
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China. zsp367@scu.edu.cn.
- Children's Medicine Key Laboratory of Sichuan Province, Chengdu, 610040, P. R. China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Liu, X., Zhou, W., Chen, L., Wang, Y., Lu, Q., Li, H., Zhang, S., Zheng, S., Liu, J., & Wang, B. (2026). Alpha-mangostin combined with doxorubicin-loaded hydrogel for the treatment of ovarian cancer. Journal of Materials Chemistry B, 14(43), 13470-13481. https://doi.org/10.1039/d6tb02158a
Vancouver
Liu X, Zhou W, Chen L, Wang Y, Lu Q, Li H, et al. Alpha-mangostin combined with doxorubicin-loaded hydrogel for the treatment of ovarian cancer. Journal of Materials Chemistry B. 2026;14(43):13470-13481. doi:10.1039/d6tb02158a
BibTeX
@article{Liu2026,
author = {Liu, Xia and Zhou, Wenjie and Chen, Lezong and Wang, Yue and Lu, Qingyang and Li, Hua and Zhang, Shuheng and Zheng, Songping and Liu, Jie and Wang, Bilan},
title = {Alpha-mangostin combined with doxorubicin-loaded hydrogel for the treatment of ovarian cancer},
journal = {Journal of Materials Chemistry B},
year = {2026},
volume = {14},
number = {43},
pages = {13470--13481},
doi = {10.1039/d6tb02158a}
}
EUVIMED